UCB PHARMA
ActiveSummary
UCB PHARMA has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16.23bn and a net result of €4.24bn, of which €3.82bn non-recurring income. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 84% of 6,141 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 26 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Food safety, FASFC
2 sitesLegal Entity Identifier
Environmental permits
Source: Omgevingsloket Vlaanderen. Flanders only: Brussels and Wallonia do not publish the applicant.
Sites & property
3 establishment units
3 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 25743G0274/00E002 | Wallonia | 18.8 ha | 1 · 1,486 m² | 9.4 m · 2 |
| 21307F0123/00P000 | Brussels | 3.9 ha | 1 · 4,201 m² | 18.7 m · 4 |
| 24040B0224/00B000 | Flanders | 1.2 ha | 1 · 1,724 m² | - |